Core Sizes: 10nm, 20nm, 30nm, 40nm, 50nm
Quantity: 20ml of each size
Concentration: 0.02 mg/ml
Formulation: Supplied in 2mM citrate
Purity: >99% reactant free
Properties
Silver nanoparticles are a great alternative to gold nanoparticles if absorption maximum is desired in between 400-500nm. Absorption in this lower range also allows for an increased dynamic range when developing multiplex experiments.
Cytodiagnostics reactant free silver nanoparticles are made using a unique proprietary protocol resulting in monodisperse particles and a narrow size distribution (CV <13%) and more than 99% reactant free. This translates to improved performance in your experiment. In addition, core size batch-to-batch variation is small ensuring that you always end up with the same product.
Storage
Store product in the dark at 4°C.
Do NOT freeze. Freezing causes irreversible aggregation of the silver nanoparticles.
When stored as specified the product is stable for at least 6 months.
Precautions and Disclaimer
This product are for R&D use only, not for drug, household, or other uses.
Download: Silver Nanoparticle Product Brochure
Diameter |
Peak SPR Wavelength (nm) |
NPS/ml* |
Wt. Conc. (mg/ml)* |
Size Dispersity (+/-nm) |
Particle Volume (nm3) |
Surface Area (nm2) |
Surface/Volume Ratio |
Particle Mass (g) |
Molar Mass (g/mol) |
Molar Concentration* |
10 |
390-405 |
3.6E+12 |
2.00E-02 |
<18% |
5.24E+02 |
3.14E+02 |
0.6 |
5.49E-18 |
3.31E+06 |
5.98E-09 |
* All concentrations as indicated at an optical density of 2.5 (OD=2.5, i.e. absorbance at peak SPR wavelength with a 1cm pathlength)
Diameter |
Peak SPR Wavelength (nm) |
NPS/ml* |
Wt. Conc. (mg/ml)* |
Size Dispersity (+/-nm) |
Particle Volume (nm3) |
Surface Area (nm2) |
Surface/Volume Ratio |
Particle Mass (g) |
Molar Mass (g/mol) |
Molar Concentration* |
20 |
390-410 |
4.6E+11 |
2.00E-02 |
<15% |
4.19E+03 |
1.26E+03 |
0.3 |
4.39E-17 |
2.65E+07 |
7.64E-10 |
* All concentrations as indicated at an optical density of 2.5 (OD=2.5, i.e. absorbance at peak SPR wavelength with a 1cm pathlength)
Diameter |
Peak SPR Wavelength (nm) |
NPS/ml* |
Wt. Conc. (mg/ml)* |
Size Dispersity (+/-nm) |
Particle Volume (nm3) |
Surface Area (nm2) |
Surface/Volume Ratio |
Particle Mass (g) |
Molar Mass (g/mol) |
Molar Concentration* |
30 |
400-410 |
1.4E+11 |
2.00E-02 |
<15% |
1.41E+04 |
2.83E+03 |
0.2 |
1.48E-16 |
8.93E+07 |
2.32E-10 |
* All concentrations as indicated at an optical density of 2.5 (OD=2.5, i.e. absorbance at peak SPR wavelength with a 1cm pathlength)
Diameter |
Peak SPR Wavelength (nm) |
NPS/ml* |
Wt. Conc. (mg/ml)* |
Size Dispersity (+/-nm) |
Particle Volume (nm3) |
Surface Area (nm2) |
Surface/Volume Ratio |
Particle Mass (g) |
Molar Mass (g/mol) |
Molar Concentration* |
40 |
405-425 |
5.7E+10 |
2.00E-02 |
<15% |
3.35E+04 |
5.03E+03 |
0.15 |
3.52E-16 |
2.12E+08 |
9.47E-11 |
* All concentrations as indicated at an optical density of 2.5 (OD=2.5, i.e. absorbance at peak SPR wavelength with a 1cm pathlength)
Diameter |
Peak SPR Wavelength (nm) |
NPS/ml* |
Wt. Conc. (mg/ml)* |
Size Dispersity (+/-nm) |
Particle Volume (nm3) |
Surface Area (nm2) |
Surface/Volume Ratio |
Particle Mass (g) |
Molar Mass (g/mol) |
Molar Concentration* |
50 |
410-430 |
2.9E+10 |
2.00E-02 |
<12% |
6.54E+04 |
7.85E+03 |
0.12 |
6.87E-16 |
4.13E+08 |
4.28E-11 |
* All concentrations as indicated at an optical density of 2.5 (OD=2.5, i.e. absorbance at peak SPR wavelength with a 1cm pathlength)